An overview of Metrion Biosciences

Dr Andrew Southan

Andy has over 25 years’ experience in life science research, with a PhD in Pharmacology from the University of London (UK). Following a move to industry, Andy worked as a brain slice electrophysiologist supporting ion channel-based CNS programmes at Wyeth (UK), before moving to Imperial College London where he published the first patch-clamp recordings from cerebellar inhibitory nerve terminals. Before joining Metrion, Andy also held positions at CeNeS Pharmaceuticals, Ionix Pharmaceuticals, BioFocus and Charles River, amassing 14 years’ experience within the CRO sector.

• LinkedIn
• Twitter
• YouTube